舒张性心力衰竭诊断和治疗专家共识
廖玉华， 杨杰孚， 张健， 程翔， 谢明星， 李新立… - 临床心血管病 …, 2020 - lcxxg.whuhzzs.com
… Anti-inflammatory therapy with canakinumab for the prevention of hospitalization for heart
failure[… Dapagliflozin in patients with heart failure and reduced ejection fraction[J].N Engl J Med,…
failure[… Dapagliflozin in patients with heart failure and reduced ejection fraction[J].N Engl J Med,…
SGLT2 抑制劑於心衰竭病人之應用
陳筱郁， 郭錦松 - 臨床醫學月刊, 2021 - airitilibrary.com
… Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10
Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American …
Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American …
[HTML][HTML] 风湿性心脏病住院患者心房颤动的研究
宋建树， 刘旭 - Hans Journal of Surgery, 2022 - hanspub.org
… in hospitalized patients with rheumatic valvular heart disease was … ejection fraction (LVEF)
were not significantly associated with atrial fibrillation in patients with rheumatic heart disease. …
were not significantly associated with atrial fibrillation in patients with rheumatic heart disease. …
薈萃分析: SGLT2 抑製劑治療心衰竭的大型隨機對照試驗臨床試驗計劃書: SGLT2 抑製劑對急性冠心症患者出院時的主要心血管不良事件的影響
謝秉儒 - 2022 - tdr.lib.ntu.edu.tw
… the composite endpoint of cardiovascular death or hospitalization for heart failure in …
cardiovascular outcomes in heart failure patients with either a reduced or preserved ejection fraction…
cardiovascular outcomes in heart failure patients with either a reduced or preserved ejection fraction…
射血分数保留性心力衰竭合并终末期肾病不同透析方式下疗效对比
傅强， 付晓华， 李志樑， 刘云峰， 文俪桦， 严全能… - 实用医学杂志, 2020 - syyxzz.com
… (heart failure with preserved ejection fraction,HF⁃pEF)合并终末期肾病(end stage renal
disease,… status,times of re⁃hospitalization due to heart failure and the im⁃provement of New York …
disease,… status,times of re⁃hospitalization due to heart failure and the im⁃provement of New York …
Effect of Shengmai injection (生脉注射液) on vascular endothelial and heart functions in patients with coronary heart disease complicated with diabetes mellitus
Y Zhang, B Lu, M Zhao, Y Rong, R Chen - Chinese journal of integrative …, 2008 - Springer
… the improvement in heart function as seen through the ejection fraction (EF) … patients who
met the inclusion standards were selected from among the inpatients who were hospitalized …
met the inclusion standards were selected from among the inpatients who were hospitalized …
[HTML][HTML] 基于网络药理学和分子对接探讨芪参益心颗粒治疗射血分数保留型心力衰竭的作用机制
陈玉林， 蒋虎刚， 王新强， 刘凯… - 中国临床药理学 …, 2023 - manu41.magtech.com.cn
… 目的:基于网络药理学和药理学实验揭示芪参益心颗粒治疗射血分数保留型心力衰竭(heart
failure with preserved ejection fraction,HFpEF)的生物活性化合物和分子机制.方法:通过TCMSP…
failure with preserved ejection fraction,HFpEF)的生物活性化合物和分子机制.方法:通过TCMSP…
[引用][C] 2 组患者性别分布, 年龄和BMI 差异无统计学意义(P= 0.407, 0.338, 0.120). 轻重度心衰2 组患者左心室EF, LGE, CO 和CI 心功能参数差异无统计学意义(P= 0.860 …
方良瑞， 肖晶晶， 范莉萍， 王健， 赵骏 - Journal of Chongqing Medical University, 2022
体重指数, 脑钠肽前体与不同类型心力衰竭的关系
郑雅芬， 王维芬， 张丽娟， 陈德良， 王智泉 - 医学研究杂志, 2017 - yxyjzz.cn
… 的心力衰竭(heart failure of preserve ejection fraction,HF-… in patients with different types of
heart failure. Methods We selected 272 patients with heart failure treated in Zhongnan Hospital …
heart failure. Methods We selected 272 patients with heart failure treated in Zhongnan Hospital …